全文获取类型
收费全文 | 7383篇 |
免费 | 463篇 |
国内免费 | 209篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 331篇 |
妇产科学 | 66篇 |
基础医学 | 1419篇 |
口腔科学 | 13篇 |
临床医学 | 592篇 |
内科学 | 1151篇 |
皮肤病学 | 29篇 |
神经病学 | 959篇 |
特种医学 | 118篇 |
外科学 | 129篇 |
综合类 | 1098篇 |
预防医学 | 1310篇 |
眼科学 | 36篇 |
药学 | 489篇 |
5篇 | |
中国医学 | 197篇 |
肿瘤学 | 88篇 |
出版年
2024年 | 7篇 |
2023年 | 105篇 |
2022年 | 206篇 |
2021年 | 338篇 |
2020年 | 267篇 |
2019年 | 195篇 |
2018年 | 205篇 |
2017年 | 215篇 |
2016年 | 280篇 |
2015年 | 287篇 |
2014年 | 453篇 |
2013年 | 482篇 |
2012年 | 448篇 |
2011年 | 523篇 |
2010年 | 462篇 |
2009年 | 441篇 |
2008年 | 365篇 |
2007年 | 359篇 |
2006年 | 307篇 |
2005年 | 282篇 |
2004年 | 224篇 |
2003年 | 221篇 |
2002年 | 139篇 |
2001年 | 152篇 |
2000年 | 135篇 |
1999年 | 139篇 |
1998年 | 83篇 |
1997年 | 87篇 |
1996年 | 55篇 |
1995年 | 61篇 |
1994年 | 81篇 |
1993年 | 45篇 |
1992年 | 40篇 |
1991年 | 45篇 |
1990年 | 34篇 |
1989年 | 36篇 |
1988年 | 40篇 |
1987年 | 19篇 |
1986年 | 22篇 |
1985年 | 27篇 |
1984年 | 26篇 |
1983年 | 12篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1980年 | 15篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 8篇 |
1976年 | 8篇 |
1973年 | 5篇 |
排序方式: 共有8055条查询结果,搜索用时 15 毫秒
61.
目的为分析中国SHIV/猕猴AIDS模型的病毒载量变化趋势,建立一种实时、灵敏、特异的针对人/猴免疫缺陷病毒的定量检测方法。方法体外转录制备RNA标准品,利用TaqManEZRT-PCR试剂盒的反应体系和针对SHIVgag保守区91个碱基的TaqMan探针和引物,建立一步法实时荧光定量RT-PCR。提取126份来自SHIV-CN97001感染恒河猴血浆病毒RNA并定量检测。结果利用梯度稀释的RNA标准品对反应体系进行优化,标准曲线下限达到2×102拷贝/ml,相关性(r>0.99)及重复性(CV=4.14%)均能达到测定要求。病毒载量的检测结果表明SHIV-CN97001在猴体内传代过程中病毒载量有先升后降的趋势,病毒载量通常在接种病毒或感染猴的全血后第14天达到高峰。血浆载量可达到105~106拷贝/ml。结论成功地建立了一步法定量SHIVRNA的实时荧光定量RT-PCR,为SHIV/恒河猴AIDS模型的建立与应用提供了灵敏的病毒载量检测方法。SHIV-CN97001的体内繁殖能力在猴体内传代过程中有所增强。 相似文献
62.
流行性乙型脑炎病毒活疫苗株SA14-14-2基因稳定性研究 总被引:1,自引:0,他引:1
目的 通过研究流行性乙型脑炎活疫苗减毒株基因稳定性,从分子水平证实流行性乙型脑炎活疫苗的遗传稳定性。方法分析流行性乙型脑炎活疫苗主种子、工作种子及其相应的疫苗病毒E蛋白基因核苷酸和氨基酸序列,并与其强毒株和基因库中乙脑病毒减毒株(AF15119)比较。结果乙脑活疫苗主种子、工作种子及其相应的疫苗病毒的E蛋白基因核苷酸序列完全相同。这些病毒E蛋白的氨基酸序列与基因库中乙脑病毒弱毒株(AF315119)比较显示第E447位点氨基酸有差异。结论乙脑病毒活疫苗减毒株遗传学特性稳定。 相似文献
63.
Horizontal transmission of hepatitis B virus infection in household contacts, Pune, India 总被引:1,自引:0,他引:1
The study was undertaken to detect the risk of infection, if any, among 193 household contacts of 40 hospitalised hepatitis patients (group I) with hepatitis B surface antigen (HBsAg) in their blood. As a control group, 103 household contacts of 27 hospitalised hepatitis patients who were negative for HBsAg (group II) were investigated. The family contacts of the former group had a significantly higher prevalence of HBV infection than those of the latter group (P less than .001). Significant differences were observed both in the prevalence of HBsAg (P less than .05) and antibody to HBsAg (anti-HBs) (P less than .025) between the two groups. IgM antibody to hepatitis B core antigen (anti-Hbc-IgM) was detected in 32 out of the 39 (82%) sera tested from the patients of group I with HBsAg. A statistically significant difference (P less than .005) of HBV prevalence was also found in the contacts of these 32 patients suffering from acute hepatitis B as compared to the contacts of the patients of group II. Overall, the children of the first group showed a significantly higher prevalence of HBsAg as compared to the second group. All the children with HBsAg were positive for HBeAg also, but were negative for anti-HBc-IgM. Anti-HBs was detected in a significantly larger number of adult females. Spouses were found to be affected more than other relatives. A significant difference (P less than .025) was noted in the number of families having HBV markers in group I (80.0%) as compared to those in group II (48.1%).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
64.
目的 研究病毒载量检测和CD4^ 计数在评价人类免疫缺陷病毒(HIV)感染者疗效中的应用效果。方法 对HIV感染者临床病例73例进行了实验室和临床观察,其中包括6例鸡尾酒治疗病例、36例中药试验性治疗病例及31例未进行治疗的感染者。主要实验室指标包括血浆病毒载量及T淋巴细胞亚群计数。结果 在进行治疗后3个月时联合治疗组的病毒载量明显低于其他两组,并且在其后保持在很低的水平,CD4^ 计数水平明显高于其他两组并在其后持续升高。在整个观察期间,中药治疗组的病毒载量检测和CD4^ 计数水平与未治疗组差异无显著性,但在临床症状观察中中药治疗组较未治疗组有明显改善。结论 病毒载量检测和CD4^ 计数试验是评价抗HIV治疗疗效的有效方法。 相似文献
65.
Diamond C Speck C Huang ML Corey L Coombs RW Krieger JN 《Journal of virological methods》2000,90(2):10-191
We sought to determine the optimal assays for cytomegalovirus (CMV) shedding in semen. Over a 2-month period, 149 HIV-1-infected men who have sex with men each provided up to three semen specimens. Specimens were tested for CMV by culture, rapid assay (shell vial) and polymerase chain reaction (PCR). By culture, 30% of seminal plasma and 28% of seminal cell specimens grew CMV. By rapid assay, results were 38 and 33%, respectively. By PCR, 56% of seminal cell specimens demonstrated CMV: 20% in a single semen specimen; 33% in two specimens; and 34% in all three specimens. Overall, 69% of men had CMV detected by PCR in at least one seminal cell specimen. By quantitative PCR, 14% had ten, 14% had 100, 16% had 1000, and 12% had 10 000 copies in 6.25 μl of semen analyzed. Adjusting for initial CD4+ cell count, men with CMV shedding demonstrated by PCR at the first visit were approximately four times as likely to shed CMV at a subsequent visit (RR 4.28, CI: 2.30–7.95). CMV shedding was associated with decreased CD4+ cell counts in peripheral blood (P=0.05). It is concluded that the PCR assay provided the greatest sensitivity among the three detection methods. 相似文献
66.
Tsai JC de Groot L Pinon JD Iacono KT Phillips JJ Seo SH Lavi E Weiss SR 《Virology》2003,312(2):369-380
Targeted recombination was carried out to select mouse hepatitis viruses (MHVs) in a defined genetic background, containing an MHV-JHM spike gene encoding either three heptad repeat 1 (HR1) substitutions (Q1067H, Q1094H, and L1114R) or L1114R alone. The recombinant virus, which expresses spike with the three substitutions, was nonfusogenic at neutral pH. Its replication was significantly inhibited by lysosomotropic agents, and it was highly neuroattenuated in vivo. In contrast, the recombinant expressing spike with L1114R alone mediated cell-to-cell fusion at neutral pH and replicated efficiently despite the presence of lysosomotropic agents; however, it still caused only subclinical morbidity and no mortality in animals. Thus, both recombinant viruses were highly attenuated and expressed viral antigen which was restricted to the olfactory bulbs and was markedly absent from other regions of the brains at 5 days postinfection. These data demonstrate that amino acid substitutions, in particular L1114R, within HR1 of the JHM spike reduced the ability of MHV to spread in the central nervous system. Furthermore, the requirements for low pH for fusion and viral entry are not prerequisites for the highly attenuated phenotype. 相似文献
67.
目的进行NuchSens HIV-1 QT和Amplicor HIV-1 monitor 1.5检测相同临床样品HIV-1病毒载量值之间的比较研究。方法收集临床样本82份,使用两种方法测定病毒载量,对病毒载量值进行统计分析。结果未测到核酸的和两种方法病毒载量对数值之差小于0.5的占88.9%;用△log10 VL〈0.5的56份样本统计两种方法的相关性,相关系数为0.956。结论NucliSens HIV-1 QT和Amphcor HIV-1 monitor 1.5两种方法测定的HIV病毒载量值有很好的相关性。 相似文献
68.
T. Uchida T. Shikata E. Tanaka K. Kiyosawa 《Virchows Archiv : an international journal of pathology》1994,424(5):465-469
The localization of hepatitis C virus (HCV) in the liver has not been well clarified. We report successful indirect immunoperoxidase staining of the HCV core antigen using polyclonal antibodies raised in rabbits and conventional formalin-fixed, paraffin-embedded needle biopsy sections of liver. The core antigen was distributed in a fine granular pattern diffusely, perisinusoidally, or focally within the hepatocellular cytoplasm of livers from patients with HCV infection. The staining tended to show a more heterogeneous pattern in terms of intensity and distribution in cases of more advanced disease. Hepatocellular carcinoma cells were also frequently stained. HCV immunostaining will provide important information on the pathogenesis and treatment of HCV-related liver diseases. 相似文献
69.
在中国发现普马拉型汉坦病毒 总被引:28,自引:11,他引:28
目的:确定我国是否存在普马拉(Puumala)病毒。方法:从我国东北地区棕背Bing肺标本中用RT-PCR扩增汉坦病毒S片段基因序列,对所扩增序列进行核苷酸序列测定和分析。结果:从我国东北地区棕背Bing肺标本中扩增出长度为926碱基对的cDNA片段,核苷酸序列测定证实为普马拉病毒S片段序列。与不同型别汉坦病毒代表株进行比较表明,此次发现为新的普马拉病毒株,系统发生分析结果表明,此次发现的病毒与普马拉病毒P360、K27、CG-820、CG-17株种系相近,同源性达到99%以上。结论:我国存在普马拉病毒,我国新发现的普马拉病毒核苷酸序列和俄罗斯远东地区普马拉病毒接近。 相似文献
70.
Chia-Chi Ku Chwan-Chuen King Ching-Yuang Lin Huei-Chu Hsu Li-Yen Chen Yi-Yuen Yueh Gwong-Jen J. Chang 《Journal of medical virology》1994,44(2):122-131
Because 21 immunized children (13%) among the 162 confirmed Japanese encephalitis (JE) cases during 1986–1991 occurred in Taiwan, we collected 320 serum samples from Taiwan children aged 15–31 and 27–44 months immediately before the 1st dose (n = 41) and 1–3 months after the 2nd dose (n = 78, 27 pairs), and immediately before (n = 58) and 1–3 months after the 3rd dose (n = 143,44 pairs) to determine neutralization antibody (Nt Ab) against the Nakayama (N) and Beijing-1 (B) strains and two Taiwan wild type JE viruses (JEV): CC-27 and CH-1392. Our Nt results showed that (1) B vaccine stimulated a better homologous Ab response than N vaccine for Nt Ab seropositivity rate (NASR), produced a higher level of Nt titer after the primary immunization [2 doses = 100% vs. 91%, geometric mean titer (GMT) = 115 vs. 22], had a greater booster effect (3 doses: 100% vs. 95%; GMT = 320 vs. 33), and showed a better capability to neutralize two local Taiwan JEV strains, particularly only after 3 doses (ave. NASR for B vs. N = 90% vs. 10%; and GMT for B vs. N = 154 vs. 1); (2) the two wild type JEV strains had different plaque morphology and antigenic variation and the CC-27 strain was not neutralized as well as the CH-1392 strain after 3 doses of vaccine (BBB or NNN or NNB); and (3) 30% of the children had lost JEV Nt Ab one year after the 2nd dose of N vaccine and natural infection with JE virus did occur among those children after immunization. In conclusion, (1) three doses of mouse-brain vaccine are the minimum requirement to protect children against the local Taiwan JEV; (2) the best strain for a JE vaccine depends on level of Nt Ab it induced, the molecular epidemiology and antigenic variation of the JEV in each local area; and (3) future vaccine must produce better B- and T-cell memory. © 1994 Wiley-Liss, Inc. 相似文献